ENTITY
retatrutide
retatrutide
PulseAugur coverage of retatrutide — every cluster mentioning retatrutide across labs, papers, and developer communities, ranked by signal.
Total · 30d
0
2 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
0
0 over 90d
TIER MIX · 90D
TOPICS
RECENT · PAGE 1/1 · 2 TOTAL
-
Eli Lilly escalates fight against black market retatrutide
Eli Lilly & Co. is intensifying its efforts to combat the illicit market for retatrutide, an experimental weight-loss drug. The company has filed lawsuits against businesses in the US, particularly in Texas, that are il…
-
Eli Lilly's Obesity Drugs Fuel 48% Revenue Growth, Retatrutide Trials Show Promise
Eli Lilly and Company reported a significant increase in its second-quarter revenue, reaching $23 billion, a 48% year-over-year growth. This surge was primarily driven by its GLP-1 drugs, Mounjaro and Zepbound, which ge…